Prof. Frank W. Sellke
University of Ottawa Heart Institute Ottawa, Ontario, Canada.
Presentation: Optimal Timing of Surgical Revascularization in Patients with Acute Myocardial Infarction
Dr. Kenza Rahmouni completed her MDCM degree at McGill University in 2020. She is now the current chief resident and she is doing her academic enrichment year in the clinical scientist program at the University of Ottawa Heart Institute. She is extremely organized, a potential superstar and an exceptional speaker with profound insights.
Her research interests include mitral valve repair and replacement, minimally invasive surgery (including minimally invasive coronary artery bypass grafts), heart valve bioprostheses, and mechanical valves, as well as women's cardiovascular health.
Sunil V. Rao
Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, NYU Langone Health, NY, USA.
Presentation: The role of blood transfusion in ACS patients with anemia: Background, Rationale, and Primary Results of the MINT Trial
Sunil V. Rao, MD is the Director of Interventional Cardiology at NYU Langone Health and the Director of the NYU Langone’s Cardiac Catheterization Laboratory in Manhattan. Additionally, he is the Professor of Medicine at NYU Grossman School of Medicine. Dr. Rao served as the chair of the Society for Cardiovascular Angiography & Interventions (SCAI) Quality Committee and was chair of the SCAI 2019 Scientific Sessions. A prolific researcher, Dr. Rao has published more than 400 peer-reviewed articles and textbook chapters. He serves as editor-in-chief of Circulation: Cardiovascular Interventions and is currently the president of the Society for Cardiovascular Angiography and Interventions. In addition to his clinical and academic accomplishments, Dr. Rao is a dedicated educator who has received numerous teaching and mentoring awards. His research has been supported by the National Institutes of Health, the American College of Cardiology, the Veterans Affairs Health Administration, and the interventional industry. He continues to present at national and international meetings and is sought out as an expert on the subspecialty.
His focus of research is on bleeding and transfusion issues in patients with ischemic heart disease, quality assessment and improvement through registries, as well as early phase clinical trials in interventional cardiology.